Your browser doesn't support javascript.
loading
Pleiotropic effects of sitagliptin versus voglibose in patients with type 2 diabetes inadequately controlled via diet and/or a single oral antihyperglycemic agent: a multicenter, randomized trial.
Matsushima, Yukiko; Takeshita, Yumie; Kita, Yuki; Otoda, Toshiki; Kato, Ken-Ichiro; Toyama-Wakakuri, Hitomi; Akahori, Hiroshi; Shimizu, Akiko; Hamaguchi, Erika; Nishimura, Yasuyuki; Kanamori, Takehiro; Kaneko, Shuichi; Takamura, Toshinari.
Afiliação
  • Matsushima Y; Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan; Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan; ERA-DM Chapter 1 Study Group, Kanazawa, I
  • Takeshita Y; Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan; Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan; ERA-DM Chapter 1 Study Group, Kanazawa, I
  • Kita Y; Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan; ERA-DM Chapter 1 Study Group, Kanazawa, Ishikawa, Japan.
  • Otoda T; Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan; ERA-DM Chapter 1 Study Group, Kanazawa, Ishikawa, Japan.
  • Kato K; Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan; ERA-DM Chapter 1 Study Group, Kanazawa, Ishikawa, Japan.
  • Toyama-Wakakuri H; Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan; ERA-DM Chapter 1 Study Group, Kanazawa, Ishikawa, Japan.
  • Akahori H; ERA-DM Chapter 1 Study Group, Kanazawa, Ishikawa , Japan.
  • Shimizu A; ERA-DM Chapter 1 Study Group, Kanazawa, Ishikawa , Japan.
  • Hamaguchi E; ERA-DM Chapter 1 Study Group, Kanazawa, Ishikawa , Japan.
  • Nishimura Y; ERA-DM Chapter 1 Study Group, Kanazawa, Ishikawa , Japan.
  • Kanamori T; Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan; ERA-DM Chapter 1 Study Group, Kanazawa, Ishikawa, Japan.
  • Kaneko S; Department of Disease Control and Homeostasis , Kanazawa University Graduate School of Medical Sciences , Kanazawa, Ishikawa , Japan.
  • Takamura T; Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan; Department of Disease Control and Homeostasis, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Ishikawa, Japan; ERA-DM Chapter 1 Study Group, Kanazawa, I
BMJ Open Diabetes Res Care ; 4(1): e000190, 2016.
Article em En | MEDLINE | ID: mdl-27110370
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: BMJ Open Diabetes Res Care Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: BMJ Open Diabetes Res Care Ano de publicação: 2016 Tipo de documento: Article